Cancer Research Technology
Log in Register
Menu

KARPAS 929 Cell Line

Invented by Abraham Karpas

Info

Antigen/Gene or Protein Targets Human multiple myeloma
Host Human
Tissue Blood
Disease Keywords Cancer; haemotology; leukaemia
Relevance The KARPAS 929 cell line is a Human Myeloma cell line useful in oncology research.
Production Details Established in 1984 from the bone marrow of a 67-year old woman diagnosed with myeloma who survived for one year after diagnosis.
Research Area Cancer, Drug Discovery & Development
Growth/Phenotype Keywords Single round to polymorphic cells growing in suspension; Hyperdiploid with complex aberrant chromosomes
Recommended Growing Conditions Doubling time approximately 30 hours. Cells grow singly in suspension. Maintain cultures between 5-20 x 105 cells/ml; 5% CO2; 37°C. Thaw ampoule and perform a cell count, spin out the DMSO and resuspend in an appropriate volume of media to give a cell concentration of 5 x 105 cells/ml. At subculture perform a cell count and maintain cultures between 5-20 x 105cells/ml, this tends to equate to a 1:3 split every 2-3 days.Culture medium: RPMI 1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS)
Cellosaurus ID CVCL_2543

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Karpas et al. 2001. Proc Natl Acad Sci U S A. 98(4):1799-804. PMID: 11172031.


Add a reference

References: 1 entry

Karpas et al. 2001. Proc Natl Acad Sci U S A. 98(4):1799-804. PMID: 11172031.


Add a reference

Inventor Information